SYNERGY BETWEEN AMOXICILLIN AND GENTAMICIN IN COMBINATION AGAINST A HIGHLY PENICILLIN-RESISTANT AND PENICILLIN-TOLERANT STRAIN OF STREPTOCOCCUS-PNEUMONIAE IN A MOUSE PNEUMONIA MODEL

In vivo synergy with beta-lactam antibiotics and aminoglycosides has b een studied only with penicillin-susceptible Streptococcus pneumoniae strains, We evaluated the interaction between amoxicillin (AMX) and ge ntamicin (GEN) on the basis of in vitro checkerboard and time-kill cur ves and of findings in a mouse model of acute bacteremic pneumonia due to a highly penicillin-resistant and -tolerant S. pneumoniae strain o f serotype 19 (penicillin and AMX MICs of 4 mu g/ml; gentamicin MIC of 16 mu g/ml). Checkerboard results at 18 h of incubation showed indiff erence, With regard to AMX alone, in vitro time-kill curves demonstrat ed synergy between AMX (1 mu g/ml) and GEN (16 mu g/ml) at 5 and 8 h o f incubation and for AMX (16 mu g/ml) in combination with GEN (16 mu g /ml) at 3, 5, and 8 h of incubation, In leukopenic mice, pulmonary kil ling curves after a single drug injection demonstrated that AMX (100 m g/kg of body weight) with GEN (16 mg/kg) was more effective than AMX a lone (P = 10(-4)), With repeated-dose treatment, a synergy was apparen t at 8 h after four injections with AMX (100 mg/kg) in combination wit h GEN (8 or 16 mg/kg) (P less than or equal to 0.05), The cumulative s urvival rate with AMX (100 mg/kg) every 8 h, combined with GEN (4 or 8 mg/kg) every 8, 12, or 24 h, was better than with AMX alone, Combined use of AMX and GEN may be a valuable therapeutic alternative for pneu mococcal pneumonia due to highly penicillin-resistant S. pneumoniae st rains.